Ceribell’s rapid seizure triage product for critical care received FDA’s Breakthrough Designation with an exclusive New Technology Add-on Payment (NTAP) from CMS. Everything about the ClarityPro product—from the innovative EEG headband to the EEG recorder and physician portal has been engineered to enable quick detection and response to non-convulsive seizure in a critical care or ED setting. In this episode of the Medtech Talk podcast, host Geoff Pardo speaks with Jane Chao, CEO of Ceribell, about the path to develop an innovative new product and her personal journey as well.
Chao’s own story started with a love of numbers, a highly exclusive spot earned in a prestigious chemistry program in Beijing, a Ph.D. in biophysics, and roles at McKinsey, Novartis, and Genentech. For Ceribell’s genesis, Chao took lessons from all of those experiences—business knowledge gained at McKinsey, and a rich, interdisciplinary scientific background—to launch a new medtech business and engineer a new device to meet a critical, unmet medical need. 
Medtech Talk Links:   <a href="https://www.healthtech.com/">Cambridge Healthtech Institute</a>    <a href="https://medtechconference.com/medtech-talk-podcast/">Medtech Talk</a> <a href="https://gildehealthcare.com/">Gilde Healthcare</a>

Episode: 180 - From Conception to Commercialization, Jane Chao and Ceribell Are Changing Lives With This Neuromonitoring Breakthrough

Ceribell’s rapid seizure triage product for critical care received FDA’s Breakthrough Designation with an exclusive New Technology Add-on Payment (NTAP) from CMS. Everything about the ClarityPro product—from the innovative EEG headband to the EEG recorder and physician portal has been engineered to enable quick detection and response to non-convulsive seizure in a critical care or [&hellip;]

Medtech Talk Episode #180

Episode: 180 - From Conception to Commercialization, Jane Chao and Ceribell Are Changing Lives With This Neuromonitoring Breakthrough